The Efficacy of Oligonol in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blinded Placebo-Controlled Trial
Maneerat Chayanupatkul(Chulalongkorn University), Pisit Tangkijvanich(Chulalongkorn University), Anuchit Chutaputti(Phramongkutklao Hospital), Waleerat Sawatdee(Chulalongkorn University)
Cited by 2
Related Papers
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
|Gastroenterology|2017|929
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
|Gastroenterology|2018|796
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
|Journal of Hepatology|2016|139
Cirrhotic cardiomyopathy: review of pathophysiology and treatment
|Hepatology International|2014|118
Correlation of Plasma and Synovial Fluid Adiponectin with Knee Osteoarthritis Severity
|Archives of Medical Research|2010|108